Fujian Aonong Biological Technology Group Incorporation Limited (SHA:603363)
China · Delayed Price · Currency is CNY 3.370
+0.020 (0.60%)
May 28, 2026, 3:00 PM CST
SHA:603363 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | -154.01 | 77.62 | 579.35 | -3,651 | -1,038 | -1,520 |
Depreciation & Amortization | 472.83 | 472.83 | 832.55 | 1,235 | 1,290 | 1,042 |
Other Amortization | 27.47 | 27.47 | 96.22 | 86.97 | 59.47 | 49.33 |
Loss (Gain) From Sale of Assets | -0.36 | -0.36 | -46.16 | 38.28 | -2.56 | 2.38 |
Asset Writedown & Restructuring Costs | 46.8 | 46.8 | 174.46 | 470.43 | 51.24 | 42.49 |
Loss (Gain) From Sale of Investments | 32.4 | 32.4 | -1,499 | 5.83 | 14.44 | 37.42 |
Provision & Write-off of Bad Debts | 23 | 23 | 55.64 | 46.16 | 24.82 | 56.75 |
Other Operating Activities | 788.5 | 328.5 | 188.72 | 874.16 | 791.48 | 555.47 |
Change in Accounts Receivable | -435.76 | -435.76 | -3,695 | -301.33 | -47.36 | -146.7 |
Change in Inventory | -320.18 | -320.18 | 455.31 | 2,073 | -1,223 | -1,290 |
Change in Accounts Payable | -94.15 | -94.15 | 2,734 | -15.19 | 796.91 | 1,640 |
Change in Other Net Operating Assets | -0.38 | -0.38 | 0.73 | 55.74 | 51.82 | 54.48 |
Operating Cash Flow | 381.31 | 152.94 | -116.78 | 984.01 | 663.64 | 524.29 |
Operating Cash Flow Growth | - | - | - | 48.27% | 26.58% | 29.13% |
Capital Expenditures | -184.05 | -232.9 | -262.68 | -511.77 | -1,499 | -2,709 |
Sale of Property, Plant & Equipment | 5.48 | 4.69 | 164.82 | 78.18 | 13.83 | 12.06 |
Cash Acquisitions | -0.33 | -0.33 | -2.1 | -56.54 | -64.89 | -63.45 |
Divestitures | 64.24 | 64.29 | 29.8 | 246.99 | -0.19 | 5.6 |
Investment in Securities | -3.7 | -4.05 | 28.15 | 3.77 | -98.41 | -19.76 |
Other Investing Activities | -4.26 | -2.76 | 2.94 | -82.71 | -54.61 | -32.2 |
Investing Cash Flow | -122.62 | -171.05 | -39.07 | -322.08 | -1,703 | -2,806 |
Long-Term Debt Issued | - | 361.5 | 957.62 | 7,534 | 6,568 | 5,995 |
Long-Term Debt Repaid | - | -795.58 | -1,403 | -8,066 | -6,440 | -4,427 |
Net Debt Issued (Repaid) | -390.73 | -434.08 | -445.76 | -532.77 | 127.84 | 1,568 |
Issuance of Common Stock | - | - | 1,709 | - | 1,618 | 1,064 |
Repurchase of Common Stock | -7.1 | -7.1 | -35.64 | -8.44 | -61.82 | -3.11 |
Common Dividends Paid | -80.75 | -84.51 | -76.39 | -294.86 | -373.67 | -345.77 |
Other Financing Activities | 10.31 | -41.06 | -15.22 | -294.26 | -89.69 | -83.36 |
Financing Cash Flow | -468.26 | -566.75 | 1,135 | -1,130 | 1,220 | 2,200 |
Foreign Exchange Rate Adjustments | -0.06 | -0.04 | 0 | -2.06 | -2.05 | -0.11 |
Net Cash Flow | -209.62 | -584.89 | 979.64 | -470.46 | 178.55 | -82.54 |
Free Cash Flow | 197.26 | -79.95 | -379.46 | 472.23 | -835.31 | -2,184 |
Free Cash Flow Margin | 2.22% | -0.94% | -4.33% | 2.43% | -3.86% | -12.11% |
Free Cash Flow Per Share | 0.09 | -0.03 | -0.44 | 0.55 | -1.08 | -3.36 |
Cash Interest Paid | 22.56 | 22.56 | 19.48 | 67.44 | 21.16 | 29.12 |
Cash Income Tax Paid | 70.94 | 78.82 | 69.39 | 108.27 | 99.93 | 85.41 |
Levered Free Cash Flow | -508.66 | -865.58 | -2,317 | 527.61 | -1,115 | -1,244 |
Unlevered Free Cash Flow | -426.14 | -776.08 | -1,910 | 871.35 | -799.01 | -982.65 |
Change in Working Capital | -855.32 | -855.32 | -498.22 | 1,878 | -526.51 | 257.88 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.